Assessment of Lung Transplant Recipients Within The Scope of International Classification of Functioning, Disability and Health
ICF-Based Assessment in Lung Transplant Recipients
1 other identifier
observational
27
1 country
1
Brief Summary
This study was aimed to evaluate the patients undergoing lung transplantation under the International Classification of Functionality, Disability and Health (ICF) and to examine the relationships between the age at which lung transplant recipients were transplanted and recipients' comorbidity levels and body structure and functions, activity and participation level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 11, 2021
CompletedFirst Submitted
Initial submission to the registry
May 6, 2022
CompletedFirst Posted
Study publicly available on registry
May 17, 2022
CompletedOctober 8, 2024
October 1, 2024
10 months
May 6, 2022
October 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Lower extremity exercise capacity assessed by 1 minute sit to stand test (STS)
Number of sit to stands performed by patients in 1 minute
at least 3 months later post operation
Upper Lower extremity exercise capacity assessed by 6 minutes pegboard and ring test
the number of rings that was moved from the lower pegs to the upper pegs and vice-versa, during a six-minute period
at least 3 months later post operation
Dyspnea assessed by mMRC dyspnea scale
modified Medical Research Council (mMRC) dyspnea scale is a self-rating tool to measure the degree of disability that breathlessness poses on day-to-day activities on a scale from 0 to 4: 0, no breathlessness except on strenuous exercise; 1, shortness of breath when hurrying on the level or walking up a slight hill; 2, walks slower than people of same age on the level because of breathlessness or has to stop to catch breath when walking at their own pace on the level; 3, stops for breath after walking ∼100 m or after few minutes on the level; and 4, too breathless to leave the house, or breathless when dressing or undressing
at least 3 months later post operation
Secondary Outcomes (2)
Sleep quality assessed by Pittsburgh sleep quality index
at least 3 months later post operation
comorbidity level assessed by Charlson comorbidity index
at least 3 months later post operation
Study Arms (1)
lung transplant
Patients who have passed at least 3 months after lung transplantation
Interventions
Evaluations of the patients will be made with scales, questionnaires and physical tests.
Eligibility Criteria
Patients who are at least 3 months past lung transplantation, who are in stable condition, and who are being followed up by the thoracic surgery clinic of the Ankara city hospital.
You may qualify if:
- At least three months have passed since the lung transplantation, without any complications at the last doctor's control
- Clinically stable and, if any, accompanying comorbidities are under control
- Volunteering to participate in research
- Patients who do not have neurological and orthopedic problems that may prevent them from performing functional tests.
You may not qualify if:
- Single lung transplant recipient
- Have orthopedic problems
- Patients who cannot cooperate and adapt.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara City Hospital
Ankara, 06800, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erdal Yekeler, Professor
Ankara City Hospital Bilkent
- STUDY DIRECTOR
Ebru Calik-Kutukcu, PhD
Hacettepe University Faculty of Physical Therapy and Rehabilitation
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc
Study Record Dates
First Submitted
May 6, 2022
First Posted
May 17, 2022
Study Start
January 27, 2021
Primary Completion
November 11, 2021
Study Completion
November 11, 2021
Last Updated
October 8, 2024
Record last verified: 2024-10